This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul G. Hattersley, MD; J. Chris Mitsuoka, PharmD; Jeffrey H. King, PharmD

Arch Intern Med. 1980;140(9):1173-1175.

Abstract
• We observed a series of patients with thromboembolic disease treated intravenously with heparin sodium and monitored by the activated coagulation time (ACT) of whole blood. When patients responded slowly, had dangerous hemorrhage, or had ACTs well outside our target range, we analyzed infusion records to determine actual infusion rates. We found the following sources of error: (1) lack of pump precision, (2) interruption of infusion, (3) errors in making up solutions, and (4) failure of infusion or charting techniques.

(Arch Intern Med 140:1173-1175, 1980)

Author Affiliations
From the Departments of Internal Medicine (Hematology and Oncology), Pathology (Dr Hattersley), and Pharmacy (Drs Mitsuoka and King), University of California Davis Medical Center, Sacramento.

Footnotes
Accepted for publication Oct 16,1979.

Reprint requests to Pathology Department, Sacramento Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817 (Dr Hattersley).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heparin Therapy for Thromboembolic Disorders: A Prospective Evaluation of 134 Cases Monitored by the Activated Coagulation Time
Hattersley et al.
JAMA 1983;250:1413-1416.
ABSTRACT